Paying users zone. Data is covered by hidden.

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Long-term (Investment) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Abbott Laboratories, long-term (investment) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net fixed asset turnover hidden hidden hidden hidden hidden
Total asset turnover hidden hidden hidden hidden hidden
Equity turnover hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories's net fixed asset turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories's total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Abbott Laboratories's equity turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Net Fixed Asset Turnover

Abbott Laboratories, net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales hidden hidden hidden hidden hidden
Net property and equipment hidden hidden hidden hidden hidden
Ratio
Net fixed asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Net Fixed Asset Turnover, Competitors
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).

2017 Calculations

1 Net fixed asset turnover = Net sales ÷ Net property and equipment
= hidden ÷ hidden = hidden

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories's net fixed asset turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.

Total Asset Turnover

Abbott Laboratories, total asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
Total asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Total Asset Turnover, Competitors
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Total Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).

2017 Calculations

1 Total asset turnover = Net sales ÷ Total assets
= hidden ÷ hidden = hidden

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories's total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Equity Turnover

Abbott Laboratories, equity turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales hidden hidden hidden hidden hidden
Total Abbott shareholders' investment hidden hidden hidden hidden hidden
Ratio
Equity turnover1 hidden hidden hidden hidden hidden
Benchmarks
Equity Turnover, Competitors
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Equity Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Equity Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).

2017 Calculations

1 Equity turnover = Net sales ÷ Total Abbott shareholders' investment
= hidden ÷ hidden = hidden

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Abbott Laboratories's equity turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.